primary care doctors aware of hypoglycemia ed visits

(See Table 2.4 for evidence grading of risk factors.) Bĥ.1 In accordance with the national standards for DSMES, all people with diabetes should participate in diabetes self-management education and receive the support needed to facilitate the knowledge, decision-making, and skills mastery necessary for diabetes self-care. CĢ.13 Risk-based screening for prediabetes and/or type 2 diabetes should be considered after the onset of puberty or after 10 years of age, whichever occurs earlier, in children and adolescents with overweight (BMI ≥85th percentile) or obesity (BMI ≥95th percentile) and who have additional risk factors for diabetes. BĢ.10 If tests are normal, repeat testing carried out at a minimum of 3-year intervals is reasonable, sooner with symptoms. CĢ.9 For all people, testing should begin at age 45 years. BĢ.8 Testing for prediabetes and/or type 2 diabetes should be considered in women with overweight or obesity planning pregnancy and/or who have one or more additional risk factors for diabetes ( Table 2.3). BĢ.7 Testing for prediabetes and/or type 2 diabetes in asymptomatic people should be considered in adults of any age with overweight (BMI 25–29.9 kg/m 2 or 23–27.4 kg/m 2 in Asian Americans) or obesity (BMI ≥30 kg/m 2 or ≥27.5 kg/m 2 in Asian Americans) and who have one or more additional risk factors for diabetes ( Table 2.3). If results are normal, testing should be repeated at a minimum of 3-year intervals, with consideration of more frequent testing depending on initial results and risk status.Ģ.6 Screening for prediabetes and type 2 diabetes with an informal assessment of risk factors or validated tools should be considered in asymptomatic adults. For all other patients, testing should begin at age 45 years.ĥ. Women who were diagnosed with GDM should have lifelong testing at least every 3 years.Ĥ. Patients with prediabetes (A1C ≥5.7%, impaired glucose tolerance, or impaired fasting glucose) should be tested yearly.ģ. Other clinical conditions associated with insulin resistance (e.g., severe obesity, acanthosis nigricans)Ģ.HDL cholesterol level 250 mg/dL (2.82 mmol/L).Hypertension (≥140/90 mmHg or on therapy for hypertension).High-risk race/ethnicity (e.g., African American, Latino, Native American, Asian American, Pacific Islander).Testing should be considered in adults with overweight or obesity (BMI ≥25 kg/m 2 or ≥23 kg/m 2 in Asian Americans) who have one or more of the following risk factors:

Primary care doctors aware of hypoglycemia ed visits